Article
A comparative study of proton-pump inhibitor tests for Chinese reflux patients in relation to the CYP2C19 genotypes.
Journal of clinical gastroenterology - 1 Jan 2000
Tseng Ping-Huei, Lee Yi-Chia, Chiu Han-Mo, Wang Hsiu-Po, Lin Jaw-Town, Wu Ming-Shiang
Abstract excerpt
BACKGROUND: The proton-pump inhibitor (PPI) test has been proposed as a valuable tool for diagnosing gastroesophageal reflux disease in Western populations. GOALS: We aim to compare the diagnostic accuracy of the PPI test using rabeprazole and pantoprazole in a Chinese population with a higher prevalence of poor PPI metabolization. STUDY: After diagnostic endoscopy, patients with gastroesophageal reflux disease...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
